These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 2370612)

  • 1. Studies of type I collagen in osteogenesis imperfecta.
    Edwards MJ; Graham JM
    J Pediatr; 1990 Jul; 117(1 Pt 1):67-72. PubMed ID: 2370612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cultured chorionic villi in a case of osteogenesis imperfecta type II: implications for prenatal diagnosis.
    Grange DK; Lewis MB; Marini JC
    Am J Med Genet; 1990 Jun; 36(2):258-64. PubMed ID: 2368816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
    Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
    Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
    Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
    Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.
    Pyott SM; Pepin MG; Schwarze U; Yang K; Smith G; Byers PH
    Genet Med; 2011 Feb; 13(2):125-30. PubMed ID: 21239989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
    Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
    Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative amounts of the collagen chains alpha 1(I), alpha 2 and alpha 1(III) in the skin of 31 patients with osteogenesis imperfecta.
    Francis MJ; Williams KJ; Sykes BC; Smith R
    Clin Sci (Lond); 1981 Jun; 60(6):617-23. PubMed ID: 6788428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of cysteine for glycine-alpha 1-691 in the pro alpha 1(I) chain of type I procollagen in a proband with lethal osteogenesis imperfecta destabilizes the triple helix at a site C-terminal to the substitution.
    Steinmann B; Westerhausen A; Constantinou CD; Superti-Furga A; Prockop DJ
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):747-52. PubMed ID: 1953667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.
    Tenni R; Biglino P; Dyne K; Rossi A; Filocamo M; Pendola F; Brunelli P; Buttitta P; Borrone C; Cetta G
    J Inherit Metab Dis; 1991; 14(2):189-201. PubMed ID: 1886404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental mosaicism and autosomal dominant mutations causing structural abnormalities of collagen I are frequent in families with osteogenesis imperfecta type III/IV.
    Lund AM; Nicholls AC; Schwartz M; Skovby F
    Acta Paediatr; 1997 Jul; 86(7):711-8. PubMed ID: 9240878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.
    Valli M; Sangalli A; Rossi A; Mottes M; Forlino A; Tenni R; Pignatti PF; Cetta G
    Eur J Biochem; 1993 Feb; 211(3):415-9. PubMed ID: 7679635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal osteogenesis imperfecta: abnormal collagen metabolism and biochemical characteristics of hypophosphatasia.
    Royce PM; Blumberg A; Zurbrügg RP; Zimmermann A; Colombo JP; Steinmann B
    Eur J Pediatr; 1988 Aug; 147(6):626-31. PubMed ID: 3181205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagen defects in lethal perinatal osteogenesis imperfecta.
    Bateman JF; Chan D; Mascara T; Rogers JG; Cole WG
    Biochem J; 1986 Dec; 240(3):699-708. PubMed ID: 3827862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
    Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
    J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial variable expressivity of osteogenesis imperfecta due to mosaicism for a lethal G382R substitution in the COL1A1 gene.
    Cohen-Solal L; Zolezzi F; Pignatti PF; Mottes M
    Mol Cell Probes; 1996 Jun; 10(3):219-25. PubMed ID: 8799376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.
    Byers PH; Tsipouras P; Bonadio JF; Starman BJ; Schwartz RC
    Am J Hum Genet; 1988 Feb; 42(2):237-48. PubMed ID: 3341380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a type I collagen alpha 2(I) glycine-586 to valine substitution in osteogenesis imperfecta type IV. Detection of the mutation and prenatal diagnosis by a chemical cleavage method.
    Bateman JF; Hannagan M; Chan D; Cole WG
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):765-70. PubMed ID: 2064612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta.
    Mottes M; Gomez Lira MM; Valli M; Scarano G; Lonardo F; Forlino A; Cetta G; Pignatti PF
    Hum Mutat; 1993; 2(3):196-204. PubMed ID: 8364588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain.
    Torre-Blanco A; Adachi E; Romanic AM; Prockop DJ
    J Biol Chem; 1992 Mar; 267(7):4968-73. PubMed ID: 1537873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite.
    Culbert AA; Lowe MP; Atkinson M; Byers PH; Wallis GA; Kadler KE
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):815-20. PubMed ID: 7487936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.